Regeneron Pharmaceuticals Collaboration Agreements

19 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
EX-10.1: LICENSE AND COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2006
First Amendment to Amended and Restated License and Collaboration Agreement by and between the Registrant and Aventis Pharmaceuticals Inc., dated May 1, 2013
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2023
Fifth Amendment to Amended and Restated License and Collaboration Agreement, dated as of June 1, 2022, by and between the Registrant, Sanofi Biotechnology SAS, and Sanofi
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Amended and Restated Immuno-Oncology License and Collaboration Agreement, dated as of June 1, 2022, by and between the Registrant and Sanofi Biotechnology SAS
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2022
First Amendment to Immuno-oncology License and Collaboration Agreement, dated as of October 6, 2021, by and between the Registrant and Sanofi Biotechnology SAS
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Fourth Amendment to Amended and Restated License and Collaboration Agreement, dated as of October 6, 2021, by and between the Registrant, Sanofi Biotechnology SAS, and Sanofi
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Third Amendment to Amended and Restated License and Collaboration Agreement, dated as of April 5, 2020, and effective as of April 1, 2020, by and between the Registrant, Sanofi...
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2020
Form of Co-Co Collaboration Agreement (Exhibit B to Master Agreement contained in Exhibit 10.4)
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2019
AMENDMENT NO. 2 TO AMENDED AND RESTATED LICENSE AND COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2015
AMENDED AND RESTATED COLLABORATION AGREEMENT By and Between SANOFI-AVENTIS US, LLC and REGENERON PHARMACEUTICALS, INC. Dated as of February 23, 2015 TABLE OF CONTENTS
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2015
FIRST AMENDMENT TO AMENDED AND RESTATED LICENSE AND COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2013
LICENSE AND COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2008
EX-10.13.4: AMENDMENT NO. 4 TO COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2006
EX-10.13.3: AMENDMENT NO. 3 TO COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2006
AMENDMENT NO. 1 TO COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2005
SECOND AMENDMENT TO COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2005
COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2003
COLLABORATION, LICENSE AND OPTION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2003
EX-10.22: FOCUSED COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
DE
2002